No Photo Available

Last Update

2016-12-15T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Thomas Hecht?

Dr. Thomas Hecht

HQ Phone: +44 20 7554 4070

Email: t***@***.uk

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Cell Medica Limited

1 Canal Side Studios 8-14 St Pancras Way

London, London NW1 0QG

United Kingdom

Company Description

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of cellular immunotherapy products for the treatment of cancer and infectious diseases. Cellular immunotherapy is a novel form of medical treatment whic ... more

Find other employees at this company (96)

Background Information

Employment History

Vice President of Marketing

Amgen Inc.

Chairman

Affimed N.V.

Co-Head of the Program for Bone Marrow Transplantation

University of Freiburg

Head

Hecht Healthcare Consulting

Executive Chairman

Delenex Therapeutics AG

Chairman

ESBATech AG

Affiliations

Board Member
Clovis Oncology, Inc.

Chairman of the Investors Advisory Board
German Kidney Foundation Support Society

Chairman of the Investors Advisory Board
Heidelberg Innovation

Director
Humabs BioMed SA

Board Member
Cytos Biotechnology AG

Board Member
Kuros Biosciences Ltd

Chairman of the Supervisory Board
R&D Directions

Education

MD

degree

Economics

Web References (138 Total References)


Dr Thomas Hecht, Chairman of ...

www.talent4boards.com [cached]

Dr Thomas Hecht, Chairman of Cell Medica, said, "In view of his professional experience as an adviser to the most important players in the healthcare industry, Andrea will add significant capabilities to Cell Medica's Board.


Kuros BioSciences - Cytos Biotechnology Archive

www.cytos.com [cached]

Dr. Thomas Hecht succeeds Dr. François L'Eplattenier as chairman of the Board of Directors.

...
Dr. Thomas Hecht succeeds Dr. François L'Eplattenier as chairman of the Board of Directors.


Affimed

www.affimed.com [cached]

Dr. Thomas Hecht, Chairman

Dr. Hecht has been the Chairman of Affimed's Supervisory Board since 2007. He is Head of Hecht Healthcare Consulting in Küssnacht, Switzerland, a biopharmaceutical consulting company founded in 2002. Dr. Hecht also serves as Chairman of the Board of Directors of Cell Medica Ltd., Delenex AG, Vaximm AG and as a Director of Humabs BioMed AG. Until the beginning of March 2015, he served as Chairman of the Supervisory Council of SuppreMol GmbH. Dr. Hecht was previously Vice President Marketing at Amgen Europe. A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation at the University of Freiburg, Germany.


Cytos Biotechnology - Board &Management

www.cytos.com [cached]

Thomas Hecht, MD, has been a member of the Board of Directors since April 2003. Since April 2010 he is Chairman of the Board of Directors and since August 2011 he acts as Executive Chairman at Cytos Biotechnology. He was vice president marketing (hematology, oncology, new products) for Amgen (Europe) AG from 1999 until 2002. Before this, he held different marketing and medical affairs positions at Amgen (Europe) AG, and at Amgen GmbH, Germany. He was co-head of the program for bone marrow transplantation, University of Freiburg i. Br., Germany, and worked as a physician at the University of Freiburg i. Br., Germany, for several years. Today, he provides services to the pharmaceutical industry in medical/marketing development and licensing strategies through HHC, a biopharmaceutical consulting company founded in 2002. He serves as chairman of the boards of Affimed Therapeutics AG and Delenex Therapeutics AG and as chairman of the advisory board of SuppreMol GmbH. He also serves as member of the board of Cellmedica Ltd.


Thomas Hecht, ...

phx.corporate-ir.net [cached]

Thomas Hecht, Chairman. Dr. Hecht has been the chairman of our supervisory board since 2007. He is head of Hecht Healthcare Consulting in Küssnacht, Switzerland, a biopharmaceutical consulting company founded in 2002. Dr. Hecht also serves as chairman of the board of directors of Cell Medica Ltd., Delenex AG and as a director of Humabs BioMed AG. Until the beginning of March 2015, he served as chairman of the supervisory council of SuppreMol GmbH. Dr. Hecht was previously Vice President Marketing at Amgen Europe. A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation at the University of Freiburg, Germany.

Similar Profiles

Other People with this Name

Other people with the name Hecht

John Hecht
Aldo Leopold Nature Center

Lisa Hecht

Phyllis Hecht
Johns Hopkins University

Charles Hecht
Pixacore

James Hecht

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory